The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:

"
Thyroglobulin type-1
".

Functional Families

Overview of the Structural Clusters (SC) and Functional Families within this CATH Superfamily. Clusters with a representative structure are represented by a filled circle.
« Back to all FunFams

FunFam 2: Insulin-like growth factor-binding protein 2

Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.

There are 13 GO terms relating to "molecular function"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
16 P08833 (/IPI) P18065 (/IPI) P18065 (/IPI) P18065 (/IPI) P18065 (/IPI) P22692 (/IPI) P22692 (/IPI) P22692 (/IPI) P22692 (/IPI) P22692 (/IPI)
(6 more)
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
15 P08833 (/TAS) P18065 (/TAS) P18065 (/TAS) P18065 (/TAS) P18065 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS)
(5 more)
Insulin-like growth factor I binding GO:0031994
Interacting selectively and non-covalently with insulin-like growth factor I.
14 A0A0B5JK49 (/IDA) A4IGH0 (/IDA) A4K8J2 (/IDA) A4K8J3 (/IDA) B3F211 (/IDA) P08833 (/IDA) P12843 (/IDA) P18065 (/IDA) P18065 (/IDA) P18065 (/IDA)
(4 more)
Insulin-like growth factor II binding GO:0031995
Interacting selectively and non-covalently with insulin-like growth factor II.
14 A4IIA2 (/ISS) B3F211 (/ISS) P13384 (/ISS) P13384 (/ISS) P18065 (/ISS) P18065 (/ISS) P18065 (/ISS) P18065 (/ISS) P24853 (/ISS) P24853 (/ISS)
(4 more)
Insulin-like growth factor I binding GO:0031994
Interacting selectively and non-covalently with insulin-like growth factor I.
10 A4IIA2 (/ISS) F1PEM7 (/ISS) P13384 (/ISS) P13384 (/ISS) P24853 (/ISS) P24853 (/ISS) P47877 (/ISS) P49705 (/ISS) Q29400 (/ISS) Q5XHC5 (/ISS)
Insulin-like growth factor II binding GO:0031995
Interacting selectively and non-covalently with insulin-like growth factor II.
8 A0A0B5JK49 (/IDA) A4IGH0 (/IDA) A4K8J2 (/IDA) A4K8J3 (/IDA) P08833 (/IDA) P12843 (/IDA) Q8JHX6 (/IDA) Q90YJ7 (/IDA)
Insulin-like growth factor binding GO:0005520
Interacting selectively and non-covalently with an insulin-like growth factor, any member of a group of polypeptides that are structurally homologous to insulin and share many of its biological activities, but are immunologically distinct from it.
3 P47876 (/IPI) P47877 (/IPI) P47879 (/IPI)
Insulin-like growth factor binding GO:0005520
Interacting selectively and non-covalently with an insulin-like growth factor, any member of a group of polypeptides that are structurally homologous to insulin and share many of its biological activities, but are immunologically distinct from it.
3 P08833 (/TAS) P21743 (/TAS) P21744 (/TAS)
Insulin-like growth factor I binding GO:0031994
Interacting selectively and non-covalently with insulin-like growth factor I.
2 P47876 (/ISO) P47877 (/ISO)
Insulin-like growth factor II binding GO:0031995
Interacting selectively and non-covalently with insulin-like growth factor II.
2 P12843 (/IPI) Q9PTH3 (/IPI)
Insulin-like growth factor II binding GO:0031995
Interacting selectively and non-covalently with insulin-like growth factor II.
2 P47876 (/ISO) P47877 (/ISO)
Insulin-like growth factor binding GO:0005520
Interacting selectively and non-covalently with an insulin-like growth factor, any member of a group of polypeptides that are structurally homologous to insulin and share many of its biological activities, but are immunologically distinct from it.
1 B3F211 (/IDA)
Insulin-like growth factor I binding GO:0031994
Interacting selectively and non-covalently with insulin-like growth factor I.
1 P12843 (/IMP)

There are 51 GO terms relating to "biological process"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Response to insulin GO:0032868
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
32 C9JMY1 (/ISS) C9JMY1 (/ISS) C9JMY1 (/ISS) C9JMY1 (/ISS) C9JMY1 (/ISS) D2GXE7 (/ISS) E3W6T5 (/ISS) E3W6T5 (/ISS) F1PEM7 (/ISS) G3H3Z6 (/ISS)
(22 more)
Regulation of insulin-like growth factor receptor signaling pathway GO:0043567
Any process that modulates the frequency, rate or extent of insulin-like growth factor receptor signaling.
15 A4IIA2 (/ISS) B3F211 (/ISS) P12843 (/ISS) P13384 (/ISS) P13384 (/ISS) P18065 (/ISS) P18065 (/ISS) P18065 (/ISS) P18065 (/ISS) P24853 (/ISS)
(5 more)
Cellular protein metabolic process GO:0044267
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
15 P08833 (/TAS) P18065 (/TAS) P18065 (/TAS) P18065 (/TAS) P18065 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS)
(5 more)
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
15 P08833 (/TAS) P18065 (/TAS) P18065 (/TAS) P18065 (/TAS) P18065 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS)
(5 more)
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
11 P08833 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS)
(1 more)
Post-translational protein modification GO:0043687
The process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome.
11 P08833 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS)
(1 more)
Positive regulation of activated T cell proliferation GO:0042104
Any process that activates or increases the rate or extent of activated T cell proliferation.
8 F1PEM7 (/ISS) P12843 (/ISS) P13384 (/ISS) P13384 (/ISS) P24853 (/ISS) P24853 (/ISS) P47877 (/ISS) Q29400 (/ISS)
Regulation of insulin-like growth factor receptor signaling pathway GO:0043567
Any process that modulates the frequency, rate or extent of insulin-like growth factor receptor signaling.
5 P12843 (/IC) P18065 (/IC) P18065 (/IC) P18065 (/IC) P18065 (/IC)
Positive regulation of activated T cell proliferation GO:0042104
Any process that activates or increases the rate or extent of activated T cell proliferation.
4 P18065 (/IDA) P18065 (/IDA) P18065 (/IDA) P18065 (/IDA)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
3 A0A0B5JK49 (/IMP) Q8JHX6 (/IMP) Q90YJ7 (/IMP)
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
3 A0A0B5JK49 (/IDA) Q8JHX6 (/IDA) Q90YJ7 (/IDA)
Regeneration GO:0031099
The regrowth of a lost or destroyed body part, such as an organ or tissue. This process may occur via renewal, repair, and/or growth alone (i.e. increase in size or mass).
3 A0A0B5JK49 (/IMP) Q8JHX6 (/IMP) Q90YJ7 (/IMP)
Response to insulin GO:0032868
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
3 F1N2P8 (/IDA) P13384 (/IDA) P13384 (/IDA)
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
2 P12843 (/IEP) P21743 (/IEP)
Response to temperature stimulus GO:0009266
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus.
2 M4Q8Z6 (/IDA) Q3HWG3 (/IDA)
Positive regulation of growth GO:0045927
Any process that activates or increases the rate or extent of growth, the increase in size or mass of all or part of an organism.
2 P24853 (/IMP) P24853 (/IMP)
Negative regulation of developmental growth GO:0048640
Any process that stops, prevents, or reduces the frequency, rate or extent of developmental growth.
2 B3F211 (/IMP) Q9PTH3 (/IMP)
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
1 Q9PTH3 (/IMP)
Regulation of cell growth GO:0001558
Any process that modulates the frequency, rate, extent or direction of cell growth.
1 P47879 (/IGI)
Glucose metabolic process GO:0006006
The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.
1 P21743 (/TAS)
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
1 P21744 (/IEP)
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
1 P12843 (/IEP)
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
1 Q9PTH3 (/IMP)
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
1 P12843 (/IEP)
Response to nutrient GO:0007584
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
1 P12843 (/IEP)
Negative regulation of DNA replication GO:0008156
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA replication.
1 Q9PTH3 (/IMP)
Negative regulation of DNA replication GO:0008156
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA replication.
1 B3F211 (/ISS)
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
1 Q9PTH3 (/IMP)
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
1 B3F211 (/ISS)
Insulin receptor signaling pathway GO:0008286
The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
1 P21743 (/IEP)
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
1 P12843 (/IEP)
Response to lithium ion GO:0010226
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus.
1 P12843 (/IEP)
Regulation of glucose metabolic process GO:0010906
Any process that modulates the rate, frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose, the aldohexose gluco-hexose.
1 P47879 (/IGI)
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
1 P21743 (/IEP)
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
1 P12843 (/IEP)
Response to retinoic acid GO:0032526
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.
1 P12843 (/IEP)
Cellular response to hormone stimulus GO:0032870
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus.
1 P12843 (/IEP)
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
1 P21744 (/TAS)
PERK-mediated unfolded protein response GO:0036499
A series of molecular signals mediated by the endoplasmic reticulum membrane stress sensor PERK (PKR-like ER kinase). Begins with activation of PERK in response to endoplasmic reticulum (ER) stress and ends with regulation of a downstream cellular process, e.g. transcription. The main substrate of PERK is the translation initiation factor eIF2alpha. Serine-phosphorylation of eIF2alpha by PERK inactivates eIF2alpha and inhibits general protein translation. In addition, eIF2alpha phosphorylation preferentially increases the translation of selective mRNAs such as ATF4 (activating transcription factor 4), which up regulates a subset of UPR genes required to restore folding capacity.
1 P08833 (/TAS)
Regulation of growth GO:0040008
Any process that modulates the frequency, rate or extent of the growth of all or part of an organism so that it occurs at its proper speed, either globally or in a specific part of the organism's development.
1 P47879 (/IGI)
Positive regulation of activated T cell proliferation GO:0042104
Any process that activates or increases the rate or extent of activated T cell proliferation.
1 P47877 (/ISO)
Tissue regeneration GO:0042246
The regrowth of lost or destroyed tissues.
1 P21743 (/IEP)
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
1 P12843 (/IEP)
Positive regulation of MAPK cascade GO:0043410
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
1 P47879 (/IGI)
Regulation of insulin-like growth factor receptor signaling pathway GO:0043567
Any process that modulates the frequency, rate or extent of insulin-like growth factor receptor signaling.
1 Q9PTH3 (/IMP)
Positive regulation of insulin-like growth factor receptor signaling pathway GO:0043568
Any process that increases the frequency, rate or extent of insulin-like growth factor receptor signaling.
1 P47879 (/IGI)
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
1 P12843 (/IEP)
Type B pancreatic cell proliferation GO:0044342
The multiplication or reproduction of pancreatic B cells, resulting in the expansion of an pancreatic B cell population. Pancreatic B cell are cells of the pancreas that secrete insulin.
1 P47879 (/IGI)
Phosphatidylinositol-mediated signaling GO:0048015
A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
1 P21743 (/TAS)
Response to steroid hormone GO:0048545
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
1 P12843 (/IEP)
Response to glucocorticoid GO:0051384
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
1 P12843 (/IEP)

There are 19 GO terms relating to "cellular component"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
75 A0A091ED61 (/ISS) A0A091ED61 (/ISS) A0A091FKJ4 (/ISS) A0A091GP01 (/ISS) A0A091I799 (/ISS) A0A091JQK7 (/ISS) A0A091KE34 (/ISS) A0A091KFW1 (/ISS) A0A091MB20 (/ISS) A0A091MIW7 (/ISS)
(65 more)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
16 F1N2P8 (/IDA) G1NGG4 (/IDA) M4Q8Z6 (/IDA) P12843 (/IDA) P13384 (/IDA) P13384 (/IDA) P18065 (/IDA) P18065 (/IDA) P18065 (/IDA) P18065 (/IDA)
(6 more)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
15 A4IIA2 (/ISS) B3F211 (/ISS) P13384 (/ISS) P13384 (/ISS) P18065 (/ISS) P18065 (/ISS) P18065 (/ISS) P18065 (/ISS) P24853 (/ISS) P24853 (/ISS)
(5 more)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
15 P08833 (/TAS) P18065 (/TAS) P18065 (/TAS) P18065 (/TAS) P18065 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS)
(5 more)
Endoplasmic reticulum lumen GO:0005788
The volume enclosed by the membranes of the endoplasmic reticulum.
11 P08833 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS) P22692 (/TAS)
(1 more)
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
4 P18065 (/HDA) P18065 (/HDA) P18065 (/HDA) P18065 (/HDA)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
3 A0A0B5JK49 (/IDA) Q8JHX6 (/IDA) Q90YJ7 (/IDA)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
2 P47877 (/HDA) P47879 (/HDA)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
2 P47876 (/ISO) P47877 (/ISO)
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
2 C9JXF9 (/IDA) P08833 (/IDA)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
1 B3F211 (/IC)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
1 P12843 (/IDA)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
1 P47877 (/ISO)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
1 P08833 (/TAS)
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
1 P47876 (/ISO)
Apical plasma membrane GO:0016324
The region of the plasma membrane located at the apical end of the cell.
1 P12843 (/IDA)
Apical plasma membrane GO:0016324
The region of the plasma membrane located at the apical end of the cell.
1 P47877 (/ISO)
Cytoplasmic vesicle GO:0031410
A vesicle found in the cytoplasm of a cell.
1 P12843 (/IDA)
Cytoplasmic vesicle GO:0031410
A vesicle found in the cytoplasm of a cell.
1 P47877 (/ISO)
CATH-Gene3D is a Global Biodata Core Resource Learn more...